Phase 1 HIV Infections trials recruiting now

All HIV Infections trials, every phase

Other phases for HIV Infections

Phase 1 HIV Infections trials

• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
  NCT06724640 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate JL18008 in Subject With HIV Immunological Non-Responders
  NCT07579741 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
  NCT07275606 · Phase: Phase 1, Phase 2 · Ages: Up to 10 Days · Sex: All (male and female) · 1 location
• A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
  NCT05418868 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 3 locations
• A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants
  NCT07525544 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• CAR-T Cells for HIV Infection
  NCT04648046 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
  NCT06665646 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 9 locations
• Dasatinib for HIV-1 Reservoir Reduction
  NCT07342491 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• First Time in Human Study of Long Acting VH4524184 Formulations
  NCT06310551 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 3 locations
• Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
  NCT07636928 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
  NCT05674656 · Phase: Phase 1, Phase 2 · Ages: 6 Years to 12 Years · Sex: All (male and female) · 8 locations
• RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
  NCT06484335 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• The Tatelo Plus Study
  NCT06508749 · Phase: Phase 1, Phase 2 · Ages: 24 Weeks to 25 Years · Sex: All (male and female) · 2 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.